Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2025-12-25 @ 12:01 AM
NCT ID:
NCT02346058
Eligibility Criteria:
1. Inclusion Criteria:
* Patients of both sexes, aged above 20 years old.
* The patient has confirmed his/her willingness to participate in the study, after being informed about all the aspects of the study that might be relevant for his/her decision to participate, and has signed and dated the informed consent form, as approved by the Institutional Review Board/ Ethics Committee (IRB/EC).
* Presence of chronic venous insufficiency which is rated between functional classes CEAP 0 and 3.(CEAP Classes: C0:no visible or palpable signs of venous disease, C1:telangiectasies or reticular veins. C2 :apparent Varicose veins, C3 :Edema)
* Diagnosed with superficial vein thrombophlebitis and have skin reaction by redness, swelling, fever and pain symptoms.
2. Exclusion Criteria:
* Known allergy to the product's ingredients
* pregnant or breastfeeding
* patient is joining to any other clinical trail
* Patient has not sign the informed consent form
* Deep vein thrombosis
* Cellulitis
* Stasis dermatitis
* The patient is taking non-steroids anti-inflammatory drugs( include oral ,topical creams or patch form)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT02346058
Study Brief:
Protocol Section:
NCT02346058